These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10356365)

  • 1. The SH3 and BH domains of the p85alpha adapter subunit play a critical role in regulating class Ia phosphoinositide 3-kinase function.
    Beeton CA; Das P; Waterfield MD; Shepherd PR
    Mol Cell Biol Res Commun; 1999 May; 1(2):153-7. PubMed ID: 10356365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SH3 domain of the phosphatidylinositol 3-kinase regulatory subunit is responsible for the formation of a sequestration complex with insulin receptor substrate-1.
    Ikegami Y; Inukai K; Awata T; Asano T; Katayama S
    Biochem Biophys Res Commun; 2008 Jan; 365(3):433-8. PubMed ID: 17991427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
    Ren SY; Xue F; Feng J; Skorski T
    Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple domains of Ruk/CIN85/SETA/CD2BP3 are involved in interaction with p85alpha regulatory subunit of PI 3-kinase.
    Borthwick EB; Korobko IV; Luke C; Drel VR; Fedyshyn YY; Ninkina N; Drobot LB; Buchman VL
    J Mol Biol; 2004 Oct; 343(4):1135-46. PubMed ID: 15476827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85alpha regulatory subunit.
    Ueki K; Algenstaedt P; Mauvais-Jarvis F; Kahn CR
    Mol Cell Biol; 2000 Nov; 20(21):8035-46. PubMed ID: 11027274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms.
    Meier TI; Cook JA; Thomas JE; Radding JA; Horn C; Lingaraj T; Smith MC
    Protein Expr Purif; 2004 Jun; 35(2):218-24. PubMed ID: 15135396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
    Kristensen SM; Siegal G; Sankar A; Driscoll PC
    J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient mice.
    Aoki K; Matsui J; Kubota N; Nakajima H; Iwamoto K; Takamoto I; Tsuji Y; Ohno A; Mori S; Tokuyama K; Murakami K; Asano T; Aizawa S; Tobe K; Kadowaki T; Terauchi Y
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E842-53. PubMed ID: 19176357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations.
    Huang CH; Mandelker D; Schmidt-Kittler O; Samuels Y; Velculescu VE; Kinzler KW; Vogelstein B; Gabelli SB; Amzel LM
    Science; 2007 Dec; 318(5857):1744-8. PubMed ID: 18079394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance.
    del Rincon JP; Iida K; Gaylinn BD; McCurdy CE; Leitner JW; Barbour LA; Kopchick JJ; Friedman JE; Draznin B; Thorner MO
    Diabetes; 2007 Jun; 56(6):1638-46. PubMed ID: 17363744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain.
    Hofmann BT; Jücker M
    Cell Signal; 2012 Oct; 24(10):1950-4. PubMed ID: 22735814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.
    Beeton CA; Chance EM; Foukas LC; Shepherd PR
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):353-9. PubMed ID: 10947948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
    Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J
    Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct metabolic regulation of beta-catenin activity by the p85alpha regulatory subunit of phosphoinositide 3-OH kinase.
    Espada J; Peinado H; Esteller M; Cano A
    Exp Cell Res; 2005 May; 305(2):409-17. PubMed ID: 15817165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
    Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
    J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases.
    Hon WC; Berndt A; Williams RL
    Oncogene; 2012 Aug; 31(32):3655-66. PubMed ID: 22120714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p85alpha gene generates three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (PI 3-Kinase), p50alpha, p55alpha, and p85alpha, with different PI 3-kinase activity elevating responses to insulin.
    Inukai K; Funaki M; Ogihara T; Katagiri H; Kanda A; Anai M; Fukushima Y; Hosaka T; Suzuki M; Shin BC; Takata K; Yazaki Y; Kikuchi M; Oka Y; Asano T
    J Biol Chem; 1997 Mar; 272(12):7873-82. PubMed ID: 9065454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of phosphoinositide 3-kinase adapter subunit variants by insulin in human skeletal muscle.
    Shepherd PR; Navé BT; Rincon J; Nolte LA; Bevan AP; Siddle K; Zierath JR; Wallberg-Henriksson H
    J Biol Chem; 1997 Jul; 272(30):19000-7. PubMed ID: 9228082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and biochemical evaluation of the interaction of the phosphatidylinositol 3-kinase p85alpha Src homology 2 domains with phosphoinositides and inositol polyphosphates.
    Surdo PL; Bottomley MJ; Arcaro A; Siegal G; Panayotou G; Sankar A; Gaffney PR; Riley AM; Potter BV; Waterfield MD; Driscoll PC
    J Biol Chem; 1999 May; 274(22):15678-85. PubMed ID: 10336465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and purification of PI3 kinase alpha and development of an ATP depletion and an alphascreen PI3 kinase activity assay.
    Boldyreff B; Rasmussen TL; Jensen HH; Cloutier A; Beaudet L; Roby P; Issinger OG
    J Biomol Screen; 2008 Dec; 13(10):1035-40. PubMed ID: 19036708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.